Thermoresponsive Nanogel–cytokine Conjugates for Spatiotemporally Controlled Modulation of Neuroinflammation
Journal of Advanced Trends in Medical Research · 2026-01 · 3 (1) · 1-8
DOI: 10.4103/atmr.atmr_155_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Trends in Medical Research, online erschienen am 02.04.2026. Verfasst von Salma Sultan Alshahrani und 12 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Neuroinflammation following acute brain injury contributes to secondary neuronal damage. Although anti-inflammatory cytokines like interleukin-10 (IL-10) show therapeutic promise, their systemic use is limited by rapid clearance, poor blood–brain barrier (BBB) penetration and off-target immunosuppression. To address these challenges, we developed a thermoresponsive nanogel system for targeted, hyperthermia-triggered cytokine delivery.
Methods
Poly (N-isopropylacrylamide-acrylic acid) nanogels with a lower critical solution temperature of 38.5°C were synthesised via microfluidic precipitation polymerisation. IL-10 was covalently conjugated to the nanogel matrix, and Angiopep-2 peptides were grafted to enable receptor-mediated BBB transcytosis. Nanogels were characterised by dynamic light scattering, differential scanning calorimetry and MALDI-TOF mass spectrometry. In vitro assays assessed thermoresponsive swelling, IL-10 release and BBB penetration using a bEnd. 3 Transwell model. In vivo efficacy was evaluated in a mouse model of traumatic brain injury using near-infrared imaging and cytokine profiling.
Results
Nanogels exhibited reversible size transitions from 120 nm at 37°C to 65 nm at 39°C, with temperature-dependent IL-10 release reaching 75% at 39°C versus 20% at 37°C over 24 h. Angiopep-2 functionalisation enhanced in vitro transcytosis 3.5-fold and increased in vivo brain accumulation to 4.7% injected dose per gram in injured cortex versus 1.2% in controls ( P < 0.01, ANOVA, n = 5). In lipopolysaccharide-stimulated BV2 cells, nanogel–IL-10 reduced tumour necrosis factor-alpha secretion by 78%. In vivo , treatment decreased microglial activation by 60% and increased Arg-1-positive cells 3.2-fold.
Conclusion
This thermoresponsive, actively targeted nanogel platform enables precise, inflammation-triggered cytokine delivery with enhanced BBB penetration. It significantly attenuates neuroinflammation in preclinical models and offers a modular framework for treating central nervous system disorders characterised by localised inflammatory activity.
Zitieren
APA
Alshahrani, S. S., Alamri, R. D., Abdulaziz, W. W., Alturkistani, O. I., Aloufi, R. A., Alshlali, O. M., Alyami, R. H., Al-mujadib, A. A., Alshehri, R. A., Hakami, W. M., Alzahrani, S. A., Alshamrani, R. A., & Mohaini, M. A. (2026). Thermoresponsive Nanogel–cytokine Conjugates for Spatiotemporally Controlled Modulation of Neuroinflammation. Journal of Advanced Trends in Medical Research, 3(1), 1-8. https://doi.org/10.4103/atmr.atmr_155_25
Vancouver
Alshahrani SS, Alamri RD, Abdulaziz WW, Alturkistani OI, Aloufi RA, Alshlali OM, et al. Thermoresponsive Nanogel–cytokine Conjugates for Spatiotemporally Controlled Modulation of Neuroinflammation. Journal of Advanced Trends in Medical Research. 2026;3(1):1-8. doi:10.4103/atmr.atmr_155_25
BibTeX
@article{Alshahrani2026,
author = {Alshahrani, Salma Sultan and Alamri, Raseel Dhafer and Abdulaziz, Wajd Waleed and Alturkistani, Omar Ibrahim and Aloufi, Reem Abduldaem and Alshlali, Osaylah Mohammed and Alyami, Reema Hamad and Al-mujadib, Azizah Abdullah and Alshehri, Reem Abdullah and Hakami, Wafa Mohammed and Alzahrani, Shahad Ahmed and Alshamrani, Rawan Ali and Mohaini, Mohammad Al},
title = {Thermoresponsive Nanogel–cytokine Conjugates for Spatiotemporally Controlled Modulation of Neuroinflammation},
journal = {Journal of Advanced Trends in Medical Research},
year = {2026},
volume = {3},
number = {1},
pages = {1--8},
doi = {10.4103/atmr.atmr_155_25}
}
EUVIMED